tirzepatide gip receptor GLP1-GIP co-agonists: a promising evolution in the treatment of type 2 diabetes | Acta Diabetologica tirzepatide gip receptor Dual Incretin

Description

Management included immediate initiation of intravenous insulin with dextrose, which was continued in the neuro-intensive care unit (NICU) postoperatively for three days

Hope you guys are enjoying this journey so far

Together, these tools provide a shift from reactive to proactive care, greater accessibility to effective treatments, and enhanced patient outcomes.Looking ahead, this combination offers the potential to: Improve patient compliance by simplifying treatment protocols Enhance early detection of changes in sleep patterns or OSA severity Promote collaborative care between patients and providers As these solutions gain traction, the future of OSA treatment looks increasingly personalized, data-driven, and effective, offering renewed hope for millions affected by this chronic condition